ESC 2023: Long-Term Aspirin Therapy Associated With Decreased Risk for Recurrent MI and Death
Relative risk for adverse outcomes decreased at four years post-MI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.